Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial - how much change in AUA symptom index and the BPH impact index is perceptible to patients?

Author： Roehrborn C.G.   Preminger G.   Newhall P.   Denstedt J.   Razvi H.   Chin L.J.   Perlmutter A.   Barzell W.   Whitmore W.   Fritzsch R.   Sanders J.   Sech S.   Womack S.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.51, Iss.1, 1998-01, pp. : 19-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years - how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

By Hudson P.B.   Boake R.   Trachtenberg J.   Romas N.A.   Rosenblatt S.   Narayan P.   Geller J.   Lieber M.M.   Elhilali M.   Norman R.   Patterson L.   Perreault J.-P.   Malek G.H.   Bruskewitz R.C.   Roy J.B.   Ko A.   Jacobsen C.A.   Stoner E.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 690-695

Elsevier

Access to resources Recommend Favorite

Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: response durability and variables potentially predicting response

By Terada N.   Aoki Y.   Ichioka K.   Matsuta Y.   Okubo K.   Yoshimura K.   Arai Y.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 701-705

Elsevier

Access to resources Recommend Favorite

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial - placebo-controlled, double-blind extension of phase III trial

By Djavan B.   Shariat S.   Fakhari M.   Ghawidel K.   Seitz C.   Partin A.W.   Roehrborn C.G.   Marberger M.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

By Elhilali M.M.   Ramsey E.W.   Barkin J.   Casey R.W.   Boake R.C.   Beland G.   Fradet Y.   Trachtenberg J.   Orovan W.L.   Schick E.   Klotz L.H.  

Urology, Vol. 47, Iss. 3, 1996-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite